Endo Inc. approved more than $3.5 million in retention bonuses for key executives, and that figure could grow, as it works to ...

Malvern-based Endo has approved $3.5 million in retention bonuses for its key executives as it works toward a merger with ...

Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion. The company’s management are clearly looking to bring cheer ...

The Maine DEP says Mallinckrodt US LLC has failed to fully remove toxic mercury contamination decades after polluting the ...

Mallinckrodt is placing a $1.6 billion settlement package on the table as it tries to bring litigation related to the US opioid crisis to a conclusion. The UK drugmaker is also planning to seek ...

Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said ...

Mallinckrodt, a pharmaceutical company, could fall to $0 in the worst-bear case scenario according to a Tuesday note from Patrick Trucchio of Berenberg. In early trading Tuesday, shares of the ...

(RTTNews) - Specialty pharmaceutical companies Mallinckrodt plc and Endo, Inc. announced Thursday that they have entered into a definitive agreement to combine in a stock and cash transaction.

– Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function, 1 also known as HRS-AKI 2 – ...

Opioid settlements with companies like Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing ...

Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function,1 also known as HRS-AKI<sup ...

– Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function,1 also known as HRS-AKI2 – Abstract #4243460: Treatment and Outcomes of Terlipressin ...